|
Sep 30
|
High Growth Tech Stocks To Watch In September 2024
|
|
Jul 30
|
Natera to Report its Second Quarter 2024 Results on August 8, 2024
|
|
Jul 29
|
Natera touts positive results for Merkel cell carcinoma surveillance test
|
|
Jul 26
|
New MultiCenter Prospective Study Demonstrates Signatera’s Clinical Utility in Merkel Cell Carcinoma
|
|
Jul 25
|
Natera (NTRA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
|
Jun 19
|
Insider Selling: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)
|
|
Jun 17
|
Natera Launches Differentiated New Feature for Prospera™ Heart Test, Enhancing Detection of Rejection for Transplant Patients
|
|
May 31
|
Director Rowan Chapman Sells Shares of Natera Inc (NTRA)
|
|
May 30
|
Natera Presents Latest in Transplant Innovation Data Across Multiple Organs at ATC 2024
|
|
May 10
|
Why Natera Is 'A Stock To Focus On' Following Its Mighty Beat-And-Raise
|
|
May 10
|
Stocks to Watch Friday: TSMC, Novavax, Nvidia, Goldman Sachs
|
|
May 10
|
Natera Inc (NTRA) Surpasses Analyst Revenue Forecasts in Q1 2024
|
|
May 10
|
Natera, Inc. (NASDAQ:NTRA) Q1 2024 Earnings Call Transcript
|
|
May 10
|
Natera Stock Charges Higher. Positive Cash Flow Arrived Early.
|
|
May 9
|
Natera Reports First Quarter 2024 Financial Results
|
|
May 3
|
New Natera Publication Bolsters Evidence for Extended Surveillance with Signatera™ in Breast Cancer
|
|
May 2
|
Insider Sale: CFO Michael Brophy Sells Shares of Natera Inc (NTRA)
|
|
May 2
|
Insider Sale: CEO and President Steven Chapman Sells Shares of Natera Inc (NTRA)
|
|
May 1
|
Natera to Report its First Quarter 2024 Results on May 9
|
|
May 1
|
Natera Launches Fetal RhD NIPT Supporting Ob/Gyn Physicians and Patients During RhIg Shortage
|